Testing effectiveness (Phase 2)Ended earlyNCT04165031
What this trial is testing
LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation
Who this might be right for
Advanced Solid TumorNon-Small Cell Lung CancerColorectal Cancer
Eli Lilly and Company 5